These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9166227)

  • 21. Fluorotyping of HLA-A by sequence-specific priming and fluorogenic probing.
    Slateva K; Camps MA; Blasczyk R
    Tissue Antigens; 1998 Nov; 52(5):462-72. PubMed ID: 9864036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid method for semiquantitative analysis of the human V beta-repertoire using TaqManR PCR.
    Lang R; Pfeffer K; Wagner H; Heeg K
    J Immunol Methods; 1997 Apr; 203(2):181-92. PubMed ID: 9149812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer.
    Pawlowski V; Révillion F; Hornez L; Peyrat JP
    Cancer Detect Prev; 2000; 24(3):212-23. PubMed ID: 10975282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Real time quantitative PCR].
    Kim DW
    Exp Mol Med; 2001 Apr; 33(1 Suppl):101-9. PubMed ID: 11708318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of erbB-2 gene copy number in breast cancer by an improved polymerase chain reaction (PCR) technique, competitively differential PCR.
    Deng G; Kim YS
    Breast Cancer Res Treat; 1999 Dec; 58(3):213-7. PubMed ID: 10718483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of gene amplification in archival tissue by differential polymerase chain reaction.
    Neubauer A; Neubauer B; He M; Effert P; Iglehart D; Frye RA; Liu E
    Oncogene; 1992 May; 7(5):1019-25. PubMed ID: 1349162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
    Livak KJ
    Genet Anal; 1999 Feb; 14(5-6):143-9. PubMed ID: 10084106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of amplification level of the c-erbB-2 proto-oncogene in human breast carcinomas: a comparative study between non-radioactive and radioactive labelling.
    Edorh A; Parache RM; N'Sossani B; Bottin MC; Merlin JL; Colosetti P; Guillemin F; Le Faou A; Rihn B
    Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):967-73. PubMed ID: 8595375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel assay for allelic discrimination that combines the fluorogenic 5' nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay.
    Glaab WE; Skopek TR
    Mutat Res; 1999 Nov; 430(1):1-12. PubMed ID: 10592313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polymerase chain reaction, cold probes and clinical diagnosis].
    Haras D; Amoros JP
    Sante; 1994; 4(1):43-52. PubMed ID: 7909267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
    Erdogan S; Ergin M; Tuncer I
    Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template.
    Sestini R; Orlando C; Zentilin L; Lami D; Gelmini S; Pinzani P; Giacca M; Pazzagli M
    Clin Chem; 1995 Jun; 41(6 Pt 1):826-32. PubMed ID: 7768000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorotyping of HLA-C: differential detection of amplicons by sequence-specific priming and fluorogenic probing.
    Luedeck H; Blasczyk R
    Tissue Antigens; 1997 Dec; 50(6):627-38. PubMed ID: 9458116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the 5' fluorogenic exonuclease assay (TaqMan) for quantitative ribosomal DNA and rRNA analysis in sediments.
    Stults JR; Snoeyenbos-West O; Methe B; Lovley DR; Chandler DP
    Appl Environ Microbiol; 2001 Jun; 67(6):2781-9. PubMed ID: 11375195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-labeled fluorescent probes for 5' nuclease assays: purification and performance evaluation.
    Rudert WA; Braun ER; Faas SJ; Menon R; Jaquins-Gerstl A; Trucco M
    Biotechniques; 1997 Jun; 22(6):1140-5. PubMed ID: 9187765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between Taq DNA polymerase and its Stoffel fragment for quantitative real-time PCR with hybridization probes.
    Wilhelm J; Pingoud A; Hahn M
    Biotechniques; 2001 May; 30(5):1052-6, 1058, 1060 passim. PubMed ID: 11355341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TaqMan™ fluorogenic detection system to analyze gene transcription in autopsy material.
    Shintani-Ishida K; Zhu BL; Maeda H
    Methods Mol Biol; 2014; 1105():117-24. PubMed ID: 24623223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bi-allelic SNP genotyping using the TaqMan® assay.
    Woodward J
    Methods Mol Biol; 2014; 1145():67-74. PubMed ID: 24816660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exonuclease-released Fluorescence Detection of Human Parvovirus B19 DNA.
    Jordan JA; Faas SJ; Braun ER; Trucco M
    Mol Diagn; 1996 Dec; 1(4):321-328. PubMed ID: 10462579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples.
    Li J; Wang F; Mamon H; Kulke MH; Harris L; Maher E; Wang L; Makrigiorgos GM
    Clin Chem; 2006 Apr; 52(4):624-33. PubMed ID: 16469859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.